Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
See Latest ArticlesProlonging microtubule dysruption enhances the immunogenicity of chronic lymphocytic leukaemia cells
Clinical and Experimental Immunology, 10/05/09
Shaha SP et al. – This phenotype was similar to the result of activating CLL cells through Toll–like receptors (TLRs), which communicate 'danger' signals from infectious pathogens. Use of PKC agonists and microtubule inhibitors to mimic TLR–signalling, and increase the immunogenicity of CLL cells, has implications for the design of chemo–immunotherapeutic strategies.
Related Articles
Arsthinol nanosuspensions: pharmacokinetics and anti-leukaemic activity on NB4 promyelocytic leukaemia cells
Journal of Pharmacy and Pharmacology, 10/07/09
Relevance Score: 87%
Folate related gene polymorphisms and susceptibility to develop childhood acute lymphoblastic leukaemia
British Journal of Haematology, 10/05/09
Relevance Score: 87%
Quantitative assessment of PTPN11 or RAS mutations at the neonatal period and during the clinical course in patients with juvenile myelomonocytic leukaemia
British Journal of Haematology, 11/04/09
Relevance Score: 85%
Incidence and reasons for late failure after allogeneic haematopoietic cell transplantation following BuCy2 in acute myeloid leukaemia
British Journal of Haematology, 10/16/09
Relevance Score: 84%
Increased frequencies of T helper type 17 cells in the peripheral blood of patients with acute myeloid leukaemia
Clinical and Experimental Immunology, 10/05/09
Relevance Score: 84%
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
Cancer Treatment Reviews, 12/04/09
IL-13 from Th2-type cells suppresses induction of antigen-specific Th1 immunity in a T-cell lymphoma
International Immunology, 12/03/09
Prioritization of cancer antigens: keeping the target in sight
Expert Review of Vaccines, 12/02/09
Sponsor
Article Search
Sponsor